CC
IHI icon

Claybrook Capital’s iShares US Medical Devices ETF IHI Stock Holding History

Claybrook Capital’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-17,742
Closed -$591K – 366
2018
Q4 		$591K Buy
+17,742
New +$614K 0.17% 73

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Claybrook Capital's IHI Position: Q1 2019 in Review

Claybrook Capital sold out of iShares US Medical Devices ETF (IHI) in Q1 2019, closing a stake of 17,742 shares — an estimated $591K sold.

Claybrook Capital first reported a position in IHI in Q4 2018 and held it in 1 quarter. The position peaked at $591K in Q4 2018. 274 funds tracked by Wall St. Rank hold IHI as of Q1 2019.

  • Claybrook Capital reported no remaining iShares US Medical Devices ETF position as of Q1 2019 after selling out during the quarter.
  • Claybrook Capital sold 17,742 iShares US Medical Devices ETF shares in Q1 2019, an estimated $591K.
  • Claybrook Capital first reported a position in iShares US Medical Devices ETF in Q4 2018 and held it in 1 quarter.
  • Claybrook Capital's iShares US Medical Devices ETF position peaked at $591K in Q4 2018.
  • 274 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.